secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2023-03-03T23:59:59+00:00
Accession:  0001285550-23-000022
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro amends CEO, CFO, COO employment agreements with enhanced severance and equity vesting
--------------------------------------------------------------------------------

- Amendments extend severance benefits to CEO Burnett, CFO D'Alessandro, and COO Sabra upon company non-renewal of term.
- Pre-amendment outstanding time-based options and restricted stock fully vest on qualifying termination (without cause, good reason, or expiration).
- Post-amendment awards: only shares scheduled to vest within 12 months of termination accelerate; exercise period reduced to 1 year.
- All three executives receive unlimited paid time off under company's Section 16 officer policy.
- Definitions of Termination Upon Expiration, Termination Without Cause, and Voluntary Termination revised for clarity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000128555023000022/0001285550-23-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000128555023000022/clpt-20230303.htm
  HTML page:      https://secwatch.observer/filing/0001285550-23-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer